Literature DB >> 15274047

Genetic disorders affecting white matter in the pediatric age.

Maja Di Rocco1, Roberta Biancheri, Andrea Rossi, Mirella Filocamo, Paolo Tortori-Donati.   

Abstract

Pediatric white matter disorders can be distinguished into well-defined leukoencephalopathies, and undefined leukoencephalopathies. The first category may be subdivided into: (a) hypomyelinating disorders; (b) dysmyelinating disorders; (c) leukodystrophies; (d) disorders related to cystic degeneration of myelin; and (e) disorders secondary to axonal damage. The second category, representing up to 50% of leukoencephalopathies in childhood, requires a multidisciplinar approach in order to define novel homogeneous subgroups of patients, possibly representing "new genetic disorders" (such as megalencephalic leukoencepahlopathy with subcortical cysts and vanishing white matter disease that have recently been identified). In the majority of cases, pediatric white matter disorders are inherited diseases. An integrated description of the clinical, neuroimaging and pathophysiological features is crucial for categorizing myelin disorders and better understanding their genetic basis. A review of the genetic disorders affecting white matter in the pediatric age, including some novel entities, is provided. Copyright 2004 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2004        PMID: 15274047     DOI: 10.1002/ajmg.b.30029

Source DB:  PubMed          Journal:  Am J Med Genet B Neuropsychiatr Genet        ISSN: 1552-4841            Impact factor:   3.568


  9 in total

Review 1.  Systematic approaches to central nervous system myelin.

Authors:  Patricia de Monasterio-Schrader; Olaf Jahn; Stefan Tenzer; Sven P Wichert; Julia Patzig; Hauke B Werner
Journal:  Cell Mol Life Sci       Date:  2012-03-23       Impact factor: 9.261

2.  Cognition in nephropathic cystinosis: pattern of expression in heterozygous carriers.

Authors:  Stephen Niemiec; Angela Ballantyne; Doris A Trauner
Journal:  Am J Med Genet A       Date:  2012-07-11       Impact factor: 2.802

3.  Genetic contributions to the midsagittal area of the corpus callosum.

Authors:  Kimberley A Phillips; Jeffrey Rogers; Elizabeth A Barrett; David C Glahn; Peter Kochunov
Journal:  Twin Res Hum Genet       Date:  2012-06       Impact factor: 1.587

4.  Hyccin, the molecule mutated in the leukodystrophy hypomyelination and congenital cataract (HCC), is a neuronal protein.

Authors:  Elisabetta Gazzerro; Simona Baldassari; Caterina Giacomini; Veronica Musante; Floriana Fruscione; Veronica La Padula; Roberta Biancheri; Sonia Scarfì; Valeria Prada; Federica Sotgia; Ian D Duncan; Federico Zara; Hauke B Werner; Michael P Lisanti; Lucilla Nobbio; Anna Corradi; Carlo Minetti
Journal:  PLoS One       Date:  2012-03-26       Impact factor: 3.240

Review 5.  How big is the myelinating orchestra? Cellular diversity within the oligodendrocyte lineage: facts and hypotheses.

Authors:  Giulio Srubek Tomassy; Valentina Fossati
Journal:  Front Cell Neurosci       Date:  2014-07-28       Impact factor: 5.505

6.  The progeroid gene BubR1 regulates axon myelination and motor function.

Authors:  Chan-Il Choi; Ki Hyun Yoo; Syed Mohammed Qasim Hussaini; Byeong Tak Jeon; John Welby; Haiyun Gan; Isobel A Scarisbrick; Zhiguo Zhang; Darren J Baker; Jan M van Deursen; Moses Rodriguez; Mi-Hyeon Jang
Journal:  Aging (Albany NY)       Date:  2016-09-12       Impact factor: 5.682

7.  ASTROCYTES: EMERGING STARS IN LEUKODYSTROPHY PATHOGENESIS.

Authors:  Angela Lanciotti; Maria Stefania Brignone; Enrico Bertini; Tamara C Petrucci; Francesca Aloisi; Elena Ambrosini
Journal:  Transl Neurosci       Date:  2013-06-01       Impact factor: 1.757

Review 8.  Myelin damage and repair in pathologic CNS: challenges and prospects.

Authors:  Arsalan Alizadeh; Scott M Dyck; Soheila Karimi-Abdolrezaee
Journal:  Front Mol Neurosci       Date:  2015-07-27       Impact factor: 5.639

9.  Canine NAPEPLD-associated models of human myelin disorders.

Authors:  K M Minor; A Letko; D Becker; M Drögemüller; P J J Mandigers; S R Bellekom; P A J Leegwater; Q E M Stassen; K Putschbach; A Fischer; T Flegel; K Matiasek; K J Ekenstedt; E Furrow; E E Patterson; S R Platt; P A Kelly; J P Cassidy; G D Shelton; K Lucot; D L Bannasch; H Martineau; C F Muir; S L Priestnall; D Henke; A Oevermann; V Jagannathan; J R Mickelson; C Drögemüller
Journal:  Sci Rep       Date:  2018-04-11       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.